share_log

Vertex Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

Vertex Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

福泰制药 | 144:拟议出售证券
美股SEC公告 ·  06/26 10:28

Moomoo AI 已提取核心信息

Vertex Pharmaceuticals Inc. officer Carmen Bozic is set to sell 2,280 shares of common stock on 06/26/2024, with an aggregate market value of $1,075,521.60. The shares were acquired on 02/17/2024 as part of a restricted stock vesting and were compensation from the issuer. This planned sale follows a recent transaction history where Bozic sold a total of 4,560 shares over the past three months, generating total gross proceeds of $2,105,716.80.
Vertex Pharmaceuticals Inc. officer Carmen Bozic is set to sell 2,280 shares of common stock on 06/26/2024, with an aggregate market value of $1,075,521.60. The shares were acquired on 02/17/2024 as part of a restricted stock vesting and were compensation from the issuer. This planned sale follows a recent transaction history where Bozic sold a total of 4,560 shares over the past three months, generating total gross proceeds of $2,105,716.80.
Vertex Pharmaceuticals Inc.官员Carmen Bozic计划于06/26/2024卖出2,280股普通股,市值合计1,075,521.60美元。这些股票于02/17/2024作为限制性股票获得,并且是来自发行人的补偿。这次计划的出售是在Bozic过去三个月总共卖出4,560股股票、总收益2,105,716.80美元交易历史之后进行的。
Vertex Pharmaceuticals Inc.官员Carmen Bozic计划于06/26/2024卖出2,280股普通股,市值合计1,075,521.60美元。这些股票于02/17/2024作为限制性股票获得,并且是来自发行人的补偿。这次计划的出售是在Bozic过去三个月总共卖出4,560股股票、总收益2,105,716.80美元交易历史之后进行的。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息